# Neuro Clinical Decision Support Templates

## Project Tracker

**Created:** January 15, 2026  
**Last Updated:** January 15, 2026  
**Target:** 50+ validated templates  
**Current Status:** 7 templates completed

---

## Legend

- âœ… = Completed and validated (90%+ score)
- ðŸ”„ = In progress / Under revision
- â¬œ = Not started

---

## COMPLETED TEMPLATES

| # | Diagnosis | Version | Validation Score | Date Completed |
|---|-----------|---------|------------------|----------------|
| 1 | MS Exacerbation | v2.0 | 92% | Jan 13, 2026 |
| 2 | New Onset Seizure | v1.1 | Pending validation | Jan 13, 2026 |
| 3 | Peripheral Neuropathy | v1.0 | Pending validation | Jan 13, 2026 |
| 4 | Headache Evaluation | v1.0 | Pending validation | Jan 13, 2026 |
| 5 | Status Migrainosus | v1.0 | Pending validation | Jan 13, 2026 |
| 6 | Diffuse Weakness | v1.0 | Pending validation | Jan 13, 2026 |
| 7 | **Status Epilepticus** | **v1.2** | **100%** | **Jan 15, 2026** |

---

## TEMPLATES TO CREATE

### SEIZURE & EPILEPSY

| Status | Diagnosis | Priority | Notes |
|--------|-----------|----------|-------|
| âœ… | New Onset Seizure | HIGH | v1.1 complete |
| âœ… | Status Epilepticus | HIGH | v1.2 complete - 100% validation; includes rapid protocol for non-specialists |
| â¬œ | Breakthrough Seizure (Known Epilepsy) | HIGH | Different from new onset |
| â¬œ | Non-Convulsive Status Epilepticus | MEDIUM | Often missed diagnosis |
| â¬œ | Alcohol Withdrawal Seizure | MEDIUM | Common in hospitalist practice |
| â¬œ | Eclampsia/Seizure in Pregnancy | MEDIUM | Special ASM considerations |
| â¬œ | Drug-Resistant Epilepsy | LOW | Subspecialty referral focus |

### STROKE & CEREBROVASCULAR

| Status | Diagnosis | Priority | Notes |
|--------|-----------|----------|-------|
| â¬œ | Acute Ischemic Stroke | HIGH | tPA/thrombectomy protocols |
| â¬œ | Intracerebral Hemorrhage | HIGH | BP management, reversal agents |
| â¬œ | Subarachnoid Hemorrhage | HIGH | Aneurysmal vs traumatic |
| â¬œ | Transient Ischemic Attack (TIA) | HIGH | Risk stratification, workup |
| â¬œ | Cerebral Venous Thrombosis | MEDIUM | Often missed, anticoagulation |
| â¬œ | Carotid/Vertebral Artery Dissection | MEDIUM | Young stroke workup |
| â¬œ | Posterior Reversible Encephalopathy (PRES) | MEDIUM | Hypertensive emergency |
| â¬œ | Reversible Cerebral Vasoconstriction (RCVS) | MEDIUM | Thunderclap headache DDx |
| â¬œ | CNS Vasculitis | LOW | Rare, comprehensive workup |
| â¬œ | Moyamoya Disease | LOW | Rare |
| â¬œ | Post-Stroke Management | MEDIUM | Secondary prevention |

### HEADACHE

| Status | Diagnosis | Priority | Notes |
|--------|-----------|----------|-------|
| âœ… | Headache Evaluation (General) | HIGH | Broad DDx approach |
| âœ… | Status Migrainosus | HIGH | Acute management |
| â¬œ | Migraine - Chronic Management | HIGH | Preventive therapy, CGRP agents |
| â¬œ | Cluster Headache | MEDIUM | Acute and preventive |
| â¬œ | Medication Overuse Headache | MEDIUM | Very common |
| â¬œ | Idiopathic Intracranial Hypertension (IIH) | MEDIUM | Diagnostic LP, management |
| â¬œ | Low Pressure Headache / SIH | MEDIUM | Post-LP, spontaneous |
| â¬œ | Trigeminal Neuralgia | MEDIUM | Facial pain DDx |
| â¬œ | New Daily Persistent Headache | LOW | Refractory cases |
| â¬œ | Thunderclap Headache Evaluation | MEDIUM | SAH, RCVS, other emergencies |
| â¬œ | Giant Cell Arteritis (Temporal Arteritis) | MEDIUM | Vision-threatening |
| â¬œ | Tension-Type Headache | LOW | Usually PCP managed |

### DEMYELINATING DISEASES

| Status | Diagnosis | Priority | Notes |
|--------|-----------|----------|-------|
| âœ… | MS Exacerbation | HIGH | v2.0 validated |
| â¬œ | MS - New Diagnosis | HIGH | Full workup, DMT initiation |
| â¬œ | MS - Chronic Management | MEDIUM | DMT monitoring, symptoms |
| â¬œ | Neuromyelitis Optica (NMOSD) | MEDIUM | AQP4+, different from MS |
| â¬œ | MOG Antibody Disease (MOGAD) | MEDIUM | Distinct entity |
| â¬œ | Transverse Myelitis | MEDIUM | Acute myelopathy DDx |
| â¬œ | Optic Neuritis | MEDIUM | Isolated vs MS-related |
| â¬œ | Acute Disseminated Encephalomyelitis (ADEM) | LOW | More common in pediatrics |
| â¬œ | Progressive Multifocal Leukoencephalopathy (PML) | LOW | JCV, immunocompromised |

### NEUROMUSCULAR DISORDERS

| Status | Diagnosis | Priority | Notes |
|--------|-----------|----------|-------|
| âœ… | Diffuse Weakness (General) | HIGH | Broad DDx approach |
| â¬œ | Guillain-BarrÃ© Syndrome (GBS) | HIGH | Acute paralysis, respiratory |
| â¬œ | Myasthenia Gravis - Exacerbation/Crisis | HIGH | Respiratory failure risk |
| â¬œ | Myasthenia Gravis - New Diagnosis | HIGH | Full workup, treatment |
| â¬œ | Myasthenia Gravis - Chronic Management | MEDIUM | Maintenance, monitoring |
| â¬œ | CIDP (Chronic Inflammatory Demyelinating) | MEDIUM | Chronic GBS variant |
| â¬œ | Amyotrophic Lateral Sclerosis (ALS) | MEDIUM | Diagnosis, symptom management |
| â¬œ | Lambert-Eaton Myasthenic Syndrome (LEMS) | LOW | Paraneoplastic |
| â¬œ | Inflammatory Myopathy (Dermatomyositis/PM) | MEDIUM | Weakness + rash |
| â¬œ | Inclusion Body Myositis | LOW | Refractory myopathy |
| â¬œ | Muscular Dystrophy (Adult) | LOW | Rare adult presentations |
| â¬œ | Myotonic Dystrophy | LOW | Multisystem |
| â¬œ | Critical Illness Myopathy/Neuropathy | MEDIUM | ICU weakness |
| â¬œ | Botulism | LOW | Rare but critical |

### NEUROPATHY

| Status | Diagnosis | Priority | Notes |
|--------|-----------|----------|-------|
| âœ… | Peripheral Neuropathy (General Evaluation) | HIGH | Broad approach |
| â¬œ | Diabetic Neuropathy | HIGH | Most common cause |
| â¬œ | Small Fiber Neuropathy | MEDIUM | Often missed |
| â¬œ | B12 Deficiency Neuropathy | MEDIUM | Reversible |
| â¬œ | Chemotherapy-Induced Neuropathy | MEDIUM | Growing population |
| â¬œ | Carpal Tunnel Syndrome | LOW | Usually PCP/hand surgery |
| â¬œ | Ulnar Neuropathy | LOW | Entrapment |
| â¬œ | Peroneal Neuropathy | LOW | Foot drop |
| â¬œ | Multifocal Motor Neuropathy | LOW | GBS mimic |
| â¬œ | Hereditary Neuropathy (CMT) | LOW | Genetic |
| â¬œ | Vasculitic Neuropathy | LOW | Mononeuritis multiplex |
| â¬œ | Autonomic Neuropathy | MEDIUM | Orthostatic, GI, cardiac |

### MOVEMENT DISORDERS

| Status | Diagnosis | Priority | Notes |
|--------|-----------|----------|-------|
| â¬œ | Parkinson's Disease - New Diagnosis | HIGH | Workup, initiation |
| â¬œ | Parkinson's Disease - Management | MEDIUM | Medication adjustments |
| â¬œ | Parkinson's Disease - Motor Fluctuations | MEDIUM | On/off, dyskinesia |
| â¬œ | Parkinson's Disease - Psychosis | MEDIUM | Common, management |
| â¬œ | Essential Tremor | MEDIUM | DDx with Parkinson's |
| â¬œ | Dystonia | LOW | Classification, treatment |
| â¬œ | Huntington's Disease | LOW | Genetic, symptom management |
| â¬œ | Tardive Dyskinesia | MEDIUM | Antipsychotic-induced |
| â¬œ | Drug-Induced Parkinsonism | MEDIUM | Reversible |
| â¬œ | Wilson's Disease | LOW | Young onset movement disorder |
| â¬œ | Progressive Supranuclear Palsy (PSP) | LOW | Atypical parkinsonism |
| â¬œ | Multiple System Atrophy (MSA) | LOW | Atypical parkinsonism |
| â¬œ | Corticobasal Degeneration | LOW | Rare |
| â¬œ | Restless Legs Syndrome | MEDIUM | Common, often OPD |

### DEMENTIA & COGNITIVE DISORDERS

| Status | Diagnosis | Priority | Notes |
|--------|-----------|----------|-------|
| â¬œ | Dementia Evaluation (General) | HIGH | Broad workup approach |
| â¬œ | Alzheimer's Disease | MEDIUM | Diagnosis, management |
| â¬œ | Vascular Dementia | MEDIUM | Risk factor modification |
| â¬œ | Lewy Body Dementia | MEDIUM | Special medication cautions |
| â¬œ | Frontotemporal Dementia | MEDIUM | Behavioral variant |
| â¬œ | Rapidly Progressive Dementia | HIGH | Urgent workup - CJD, autoimmune |
| â¬œ | Normal Pressure Hydrocephalus (NPH) | MEDIUM | Treatable dementia |
| â¬œ | Creutzfeldt-Jakob Disease (CJD) | LOW | Rare but important DDx |
| â¬œ | Autoimmune Dementia/Encephalopathy | MEDIUM | Treatable |
| â¬œ | Mild Cognitive Impairment (MCI) | MEDIUM | Early intervention |
| â¬œ | Delirium vs Dementia | HIGH | Acute confusion workup |
| â¬œ | Wernicke-Korsakoff Syndrome | MEDIUM | Thiamine deficiency |

### CNS INFECTIONS

| Status | Diagnosis | Priority | Notes |
|--------|-----------|----------|-------|
| â¬œ | Bacterial Meningitis | HIGH | Emergency, empiric treatment |
| â¬œ | Viral Meningitis | MEDIUM | Supportive care focus |
| â¬œ | HSV Encephalitis | HIGH | Time-sensitive treatment |
| â¬œ | Autoimmune Encephalitis | HIGH | Often missed, treatable |
| â¬œ | Fungal Meningitis | MEDIUM | Immunocompromised |
| â¬œ | TB Meningitis | MEDIUM | Chronic meningitis |
| â¬œ | Neurocysticercosis | LOW | Endemic areas |
| â¬œ | Brain Abscess | MEDIUM | Neurosurgery consult |
| â¬œ | HIV-Associated Neurocognitive Disorder | LOW | AIDS dementia complex |
| â¬œ | Progressive Multifocal Leukoencephalopathy | LOW | JCV encephalitis |
| â¬œ | Neurosyphilis | LOW | Great imitator |
| â¬œ | Lyme Neuroborreliosis | MEDIUM | Endemic areas |

### NEURO-ONCOLOGY

| Status | Diagnosis | Priority | Notes |
|--------|-----------|----------|-------|
| â¬œ | Brain Metastases | HIGH | Common, management |
| â¬œ | Glioblastoma (GBM) | MEDIUM | Primary brain tumor |
| â¬œ | Leptomeningeal Carcinomatosis | MEDIUM | CSF cytology |
| â¬œ | Paraneoplastic Neurological Syndrome | MEDIUM | Antibody panels |
| â¬œ | Spinal Cord Compression (Malignant) | HIGH | Oncologic emergency |
| â¬œ | Meningioma | LOW | Often incidental |
| â¬œ | Primary CNS Lymphoma | LOW | Immunocompromised |
| â¬œ | Radiation-Induced Neurologic Injury | LOW | Delayed complications |

### SPINAL CORD DISORDERS

| Status | Diagnosis | Priority | Notes |
|--------|-----------|----------|-------|
| â¬œ | Acute Myelopathy Evaluation | HIGH | Broad DDx, urgent MRI |
| â¬œ | Cervical Myelopathy (Degenerative) | MEDIUM | Common, surgical referral |
| â¬œ | Transverse Myelitis | MEDIUM | See Demyelinating |
| â¬œ | Spinal Cord Infarction | LOW | Rare |
| â¬œ | Syringomyelia | LOW | Rare |
| â¬œ | Subacute Combined Degeneration | LOW | B12 deficiency |
| â¬œ | Cauda Equina Syndrome | HIGH | Surgical emergency |
| â¬œ | Epidural Abscess | HIGH | Surgical emergency |

### AUTOIMMUNE & INFLAMMATORY

| Status | Diagnosis | Priority | Notes |
|--------|-----------|----------|-------|
| â¬œ | Autoimmune Encephalitis | HIGH | NMDAR, LGI1, etc. |
| â¬œ | Neurosarcoidosis | MEDIUM | Multisystem |
| â¬œ | CNS Vasculitis | LOW | Rare |
| â¬œ | Susac Syndrome | LOW | Rare |
| â¬œ | Neuro-Behcet's | LOW | Rare |
| â¬œ | Stiff Person Syndrome | LOW | Rare |
| â¬œ | Hashimoto's Encephalopathy (SREAT) | LOW | Diagnosis of exclusion |

### FUNCTIONAL & PSYCHIATRIC

| Status | Diagnosis | Priority | Notes |
|--------|-----------|----------|-------|
| â¬œ | Functional Neurological Disorder (FND) | MEDIUM | Positive diagnosis |
| â¬œ | Psychogenic Non-Epileptic Spells (PNES) | MEDIUM | Video EEG confirmation |
| â¬œ | Functional Weakness | MEDIUM | Clinical signs |
| â¬œ | Functional Movement Disorder | LOW | Subspecialty |

### NEUROCRITICAL CARE

| Status | Diagnosis | Priority | Notes |
|--------|-----------|----------|-------|
| âœ… | Status Epilepticus | HIGH | v1.2 complete - see Seizure section |
| â¬œ | Elevated ICP Management | HIGH | General approach |
| â¬œ | Brain Death Evaluation | MEDIUM | Legal/ethical protocol |
| â¬œ | Anoxic Brain Injury / Prognostication | MEDIUM | Post-cardiac arrest |
| â¬œ | Neuromuscular Respiratory Failure | HIGH | GBS, MG, ALS |
| â¬œ | Hypertensive Encephalopathy | MEDIUM | BP management |

### OTHER / MISCELLANEOUS

| Status | Diagnosis | Priority | Notes |
|--------|-----------|----------|-------|
| â¬œ | Syncope Evaluation (Neuro Perspective) | MEDIUM | DDx with seizure |
| â¬œ | Vertigo / Dizziness Evaluation | HIGH | Central vs peripheral |
| â¬œ | Bell's Palsy | MEDIUM | Facial weakness DDx |
| â¬œ | Horner Syndrome | LOW | Localization |
| â¬œ | Nystagmus Evaluation | LOW | Central vs peripheral |
| â¬œ | Post-Concussion Syndrome | MEDIUM | Common |
| â¬œ | Traumatic Brain Injury (Mild/Moderate) | MEDIUM | ED evaluation |
| â¬œ | Chronic Traumatic Encephalopathy (CTE) | LOW | Emerging area |
| â¬œ | Sleep Apnea (Neurologic Aspects) | LOW | Usually sleep medicine |
| â¬œ | Narcolepsy | LOW | Sleep medicine |

---

## PRIORITY SUMMARY

### HIGH PRIORITY (Next to Create)
1. Status Epilepticus
2. Acute Ischemic Stroke
3. Guillain-BarrÃ© Syndrome (GBS)
4. Myasthenia Gravis - Exacerbation/Crisis
5. Bacterial Meningitis
6. HSV Encephalitis
7. Autoimmune Encephalitis
8. Rapidly Progressive Dementia
9. Acute Myelopathy Evaluation
10. Intracerebral Hemorrhage

### MEDIUM PRIORITY
- Remaining stroke subtypes
- Parkinson's Disease templates
- Remaining headache subtypes
- MS variants (NMOSD, MOGAD)
- Common neuropathies
- Dementia subtypes
- CNS infections

### LOW PRIORITY
- Rare diagnoses
- Subspecialty-focused conditions
- Primarily outpatient management

---

## STATISTICS

| Category | Completed | In Progress | Not Started | Total |
|----------|-----------|-------------|-------------|-------|
| Seizure/Epilepsy | 2 | 0 | 5 | 7 |
| Stroke/Cerebrovascular | 0 | 0 | 11 | 11 |
| Headache | 2 | 0 | 9 | 11 |
| Demyelinating | 1 | 0 | 8 | 9 |
| Neuromuscular | 1 | 0 | 13 | 14 |
| Neuropathy | 1 | 0 | 10 | 11 |
| Movement Disorders | 0 | 0 | 14 | 14 |
| Dementia/Cognitive | 0 | 0 | 12 | 12 |
| CNS Infections | 0 | 0 | 12 | 12 |
| Neuro-oncology | 0 | 0 | 8 | 8 |
| Spinal Cord | 0 | 0 | 8 | 8 |
| Autoimmune/Inflammatory | 0 | 0 | 7 | 7 |
| Functional/Psychiatric | 0 | 0 | 4 | 4 |
| Neurocritical Care | 1 | 0 | 5 | 6 |
| Other/Miscellaneous | 0 | 0 | 10 | 10 |
| **TOTAL** | **7** | **0** | **127** | **134** |

---

## NOTES

- Templates should follow neuro-builder SKILL v2.2 format
- All templates require neuro-checker validation (target 90%+)
- Physician review required before clinical deployment
- Consider grouping similar diagnoses for efficiency (e.g., all Parkinson's templates together)
- LP reference guide available for conditions requiring CSF analysis
- Some conditions may need separate ED vs Outpatient versions

---

## CHANGE LOG

**January 15, 2026 (Update 2)**
- Status Epilepticus v1.2 completed and validated (100% score)
  - Includes comprehensive NORSE/FIRES immunotherapy protocol
  - Added Appendix C: Rapid Protocol for Non-Specialists ("3 AM Protocol")
  - Evidence-based updates: dual LEV dosing, ketamine timing, brivaracetam
- Total completed templates: 7

**January 15, 2026**
- Initial tracker created
- 134 diagnoses identified across 15 categories
- 6 templates previously developed (validation status mixed)
- Priority tiers assigned
